CRWD Stock: Buy or Sell? Price Target & Forecast

CRWD CrowdStrike Holdings Inc As of Sep 3, 2026

$203.42

High-growth platform play on AI-driven cybersecurity; valuation stretched, profitability still nascent, insider selling heavy.

Setup: growth Confidence: 65 Horizon: 6-12 months Risk: elevated Category: Large-Cap Growth (Cybersecurity SaaS)

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals CRWD's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

29% YoY revenue growth, 5-year CAGR 40.6%, gross margin 74.8% shows pricing power. AI/Falcon integration emerging catalyst. $208B market cap + $226B EV reflects scale; high beta (1.21) offers upside leverage in risk-on environments. Cybersecurity spend structural tailwind.

▼ Bear Case

P/S 47.8x, P/B 25x, price-to-FCF 185x are all extreme. Net margin -3.38%, operating margin -6.1% — unprofitable despite scale. Insider selling 35:1 (1,702 sales vs 49 buys, $1.18M sold vs $535K bought) signals insiders pruning exposure. Valuation leaves zero margin for execution stumble or macro slowdown.

Valuation

overvalued — score 28/100

Multiples far exceed historical and peer norms for software. Revenue multiple (P/S 47.8x) implies zero margin for deceleration; price-to-FCF 185x assumes capital efficiency that data does not yet support. Growth is strong (29% YoY, 40.6% 5Y CAGR), but profitability absent. Fair value circa $140-165 if margins remain negative; $200+ requires path to 10%+ operating margin within 2-3Y visible in guidance.

Technical Levels

Support · $195.00 (Recent session low (1-day); prior support zone) · $180.00 (50-day moving average proxy (52-week midpoint $159 suggests support ~$170-180)) · $160.00 (Technical floor if macro/earnings shock; ~30% downside)

Resistance · $215.00 (Prior day close; immediate overhead) · $230.00 (Recent swing high; psychological round) · $233.88 (52-week high; strong resistance)

RSI: not provided

Financial Health

Score 72/100. Liquidity position strong (current ratio 1.77, quick 1.68). No visible debt burden. However, unprofitability and insider selling erode confidence in long-term health. Burn rate and reinvestment profile unknown from data; assume high capex/R&D.

Catalysts

Q2 2024 Earnings	likely next 4-8 weeks (pending exact calendar)	high — revenue growth rate, operating margin progress, and guidance will reset valuation expectations. Miss could trigger 15-25% reversal.
Falcon AI Platform / GPT integration adoption	ongoing into H2 2024	medium-high — early wins on OpenAI/Falcon could accelerate ARR and justify current multiples. Slow adoption raises questions.
Competitive pressure from Palo Alto Networks, Microsoft	continuous	medium — if market share loss emerges in customer wins, growth deceleration likely.
Insider selling trend continuation or reversal	real-time	medium — sustained heavy selling (1,702 vs 49 buys) may signal loss of conviction; reversal would be bullish re-rate signal.

Risk Flags

Extreme valuation multiples (P/S 48x, price-to-FCF 185x) leave no room for deceleration or profit miss.

Heavy insider selling (35:1 ratio) suggests executives trimming exposure; may reflect near-term or longer-term concern.

Unprofitable on net/operating basis despite $208B market cap; path to sustainable margins unclear in data.

RSI not provided; 1-day -5.4% move suggests volatility. Monitor technicals separately.

EV/EBITDA negative indicates EBITDA loss or distortion; valuation based on growth, not cash generation, today.

Provider data shows no debt-to-equity, ROE, ROIC — limit full balance-sheet confidence. Assume illiquid or atypical structure.

See CRWD's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock CRWD free →

More Analyses

NVDA

AAPL

TSLA

MSFT

AMZN

GOOGL

CRWD FAQ

Is CRWD a buy right now?

CrowdStrike Holdings Inc's current read is a growth setup with 65 confidence over a 6-12 months horizon. Valuation: overvalued. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is CRWD overvalued?

overvalued (valuation score 28/100). Multiples far exceed historical and peer norms for software. Revenue multiple (P/S 47.8x) implies zero margin for deceleration; price-to-FCF 185x assumes capital efficiency that data does not yet support. Growth is strong (29% YoY, 40.6% 5Y CAGR), but profitability absent. Fair value circa $140-165 if margins remain negative; $200+ requires path to 10%+ operating margin within 2-3Y visible in guidance.

What are the risks of buying CRWD?